Androgen receptor gene amplification: A novel molecular mechanism for endocrine therapy resistance in human prostate cancer
Authors:
- 1 January 1996
- journal article
- research article
- Published by Taylor & Francis in Scandinavian Journal of Clinical and Laboratory Investigation
- Vol. 56 (sup226) , 57-63
Abstract
Since the development and growth of the prostate cancer is highly dependent on androgens, androgen deprivation therapy continues to be the treatment of choice for patients with advanced prostate cancer. The therapy is very effective, but responses are often short-lived. We describe here a novel molecular mechanism that may explain why prostate cancer cells become resistant to hormonal therapy. Amplification of the androgen receptor (AR) gene was found to be selected for during androgen deprivation therapy in 23% of prostate cancer patients who experienced local tumor recurrence. Amplification leads to increased expression of the AR gene, which enables the cancer cells to more effectively utilize the residual low levels of androgens for sustaining cell growth. Discovery of AR amplification as a possible molecular mechanism of therapy resistance in prostate cancer should prove useful for development of more effective endocrine therapy regimens as well as diagnostic and predictive tests for therapy failure.Keywords
This publication has 11 references indexed in Scilit:
- Steroid hormone receptors: Many Actors in search of a plotCell, 1995
- Mutation of the Androgen-Receptor Gene in Metastatic Androgen-Independent Prostate CancerNew England Journal of Medicine, 1995
- In vivo amplification of the androgen receptor gene and progression of human prostate cancerNature Genetics, 1995
- Improved technique for analysis of formalin‐fixed, paraffin‐embedded tumors by fluorescence in situ hybridizationCytometry, 1994
- Androgen receptor gene mutations in human prostate cancerThe Journal of Steroid Biochemistry and Molecular Biology, 1993
- Comparative Genomic Hybridization for Molecular Cytogenetic Analysis of Solid TumorsScience, 1992
- Androgen receptor gene mutations in human prostate cancer.Proceedings of the National Academy of Sciences, 1992
- ERBB2 amplification in breast cancer analyzed by fluorescence in situ hybridization.Proceedings of the National Academy of Sciences, 1992
- The human androgen receptor: Structure/function relationship in normal and pathological situationsThe Journal of Steroid Biochemistry and Molecular Biology, 1992
- Tissue-specific and hormonal regulations of human prostate-specific glandular kallikreinBiochemistry, 1992